Myovant Sciences Ltd (MYOV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 12-2017 | 09-2017 | 06-2017 | 03-2017 | 12-2016 | |
| Operating Expenses | 41,515 | 30,311 | 21,890 | 22,946 | 9,056 |
| Operating Income | -41,515 | -30,311 | -21,890 | -22,946 | -9,056 |
| Interest Expense | 904 | 0 | 0 | 0 | 0 |
| Other Income | 429 | 138 | -342 | 1,157 | 1,002 |
| Pre-tax Income | -41,990 | -30,173 | -22,232 | -21,789 | -8,054 |
| Income Tax | -213 | -265 | 1,085 | -114 | 29 |
| Net Income Continuous | -41,777 | -29,908 | -23,317 | -21,675 | -8,083 |
| Net Income | $-41,777 | $-29,908 | $-23,317 | $-21,675 | $-8,083 |
| EPS Basic Total Ops | -0.70 | -0.50 | -0.39 | -0.26 | -0.15 |
| EPS Basic Continuous Ops | -0.70 | -0.50 | -0.39 | -0.27 | -0.15 |
| EPS Diluted Total Ops | -0.70 | -0.50 | -0.39 | -0.26 | -0.15 |
| EPS Diluted Continuous Ops | -0.70 | -0.50 | -0.39 | -0.27 | -0.15 |
| EBITDA(a) | $-41,062 | $-30,257 | $-21,840 | $-22,894 | $-9,048 |